Neurokinin 3 Receptor Antagonism Rapidly Improves Vasomotor Symptoms With Sustained Duration of Action

Obstetrical and Gynecological Survey- United States

doi 10.1097/ogx.0000000000000665

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

C-Terminal Truncation of the Neurokinin-2 Receptor Causes Enhanced and Sustained Agonist-Induced Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Effects of Neurokinin-1 Receptor Agonism and Antagonism in the Rostral Ventromedial Medulla of Rats With Acute or Persistent Inflammatory Nociception

Neuroscience
Neuroscience
2010English

Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

Presence of Vasomotor Symptoms Is Associated With Lower Bone Mineral Density

Menopause
GynecologyObstetrics
2009English

Vasomotor Symptoms and Depression in Women, Part 2. Treatments That Cause Remission and Prevent Relapses of Major Depressive Episodes Overlap With Treatments for Vasomotor Symptoms

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2009English

Reversal of Parkinsonian Symptoms in Primates by Antagonism of Excitatory Amino Acid Transmission: Potential Mechanisms of Action

Neuroscience and Biobehavioral Reviews
Physiological PsychologyNeuropsychologyBehavioral NeuroscienceCognitive Neuroscience
1997English

Critical Appraisal of Paroxetine for the Treatment of Vasomotor Symptoms

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2015English

Dealing With Vasomotor Symptoms in Patients With Breast Cancer, What Options Do We Have?

International Journal of Family & Community Medicine
2018English

Possible Mechanism of Action of Neurokinin-1 Receptors (NK1R) Antagonists

Journal of Pharmacy and Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy